DRUG
NASDAQ · Biotechnology
Bright Minds Biosciences Inc
$18.96
-2.59 (-12.02%)
Open$22.10
Previous Close$21.55
Day High$22.48
Day Low$18.10
52W High$170.00
52W Low$68.02
Volume—
Avg Volume460
Market Cap782.86M
P/E Ratio—
EPS$-2.90
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+42.1% upside
Current
$18.96
$18.96
Target
$26.95
$26.95
$16.82
$26.95 avg
$32.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 177.09M | 163.76M | 147.32M |
| Net Income | 34.74M | 43.56M | 40.99M |
| Profit Margin | 19.6% | 26.6% | 27.8% |
| EBITDA | 73.10M | 70.32M | 54.60M |
| Free Cash Flow | 20.82M | 31.20M | 18.21M |
| Rev Growth | -5.5% | +4.9% | +20.1% |
| Debt/Equity | 0.67 | 0.83 | 0.74 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |